Prima BioMed (ASX:PRR, NASDAQ: PBMD) is a globally active biotechnology company that is striving to become a leader in the development of immunotherapeutic products. With operations based in Australia, Germany and France, Prima BioMed is dedicated to bringing innovative treatment options to market for patients and to maximizing value for shareholders.
Contact This CompanyThere are no reviews forPrima BioMed.